GeneDx retweeted
John Wollman @KomodoHealth discusses how the company and @GeneDx are leveraging longitudinal patient data with genomic and phenotypic data to shorten rare disease diagnostic odysseys, accelerate natural hist studies, and enable better clinical decisions.
globalgenes.org/raredaily/us…
GeneDx retweeted
Another clip from this week's #HealthcareUnfiltered podcast with @GeneDx President and CEO, Katherine Stueland who describes how the focus on rare diseases using genomics will help patients world-wide. An inspiring interview streaming everywhere.
podcasts.apple.com/us/podcas…
GeneDx retweeted
Tom on #HealthcareUnfiltered, you're in for a treat as I host the President & CEO of @GeneDx Katherine Stueland who under her leadership, the company is making major strides in combatting "rare diseases' through genomics.
Wide range interview W many lessons learned. Pls tune in
GeneDx retweeted
We’re proud to partner with @GeneDx to launch a Sponsored Genetic Testing Program for eligible patients in the U.S. with suspected Niemann-Pick disease type C (NPC).
Read the press release: businesswire.com/news/home/2…
#RareDisease #NPC #GeneticTesting
GeneDx retweeted
The countdown is officially on! In just 5 days, curious minds, bold ideas, and big neonatal questions collide at Delphi 2026 in Fort Lauderdale.✨🎤
If you're not able to join us in person, be sure to follow along on our social media; we will be sharing live updates throughout. 🙌
Huge thank you to our amazing exhibitors and sponsors. We couldn't have done this without your support:
→ @ChiesiGroup
→ @DrBrownsMedical
→ @GEHealthCare
→ @Pampers
→ @NSUFlorida
→ @prolacta
→ @meadjohnson
→ @Nicklaus4Kids
→ @ONYBiotech
→ @CergenX
→ @neurobell_
→ @Nemours
→ @GeneDx
→ @VTOxfordNetwork
→ @AbbottNews
→ @LABORIEMEDICAL
→ @MarchofDimes
→ @visitlauderdale
#DelphiConference2026 #NeonatalInnovation
GeneDx retweeted
In this short video, Mimi C. Lee, MD, PhD, explains the mechanism of whole genome and exome testing, highlighting @GeneDx's ExomeDx test and GenomeDx tests.
Watch the full interview with Lee, and learn more about genetic testing: contemporarypediatrics.com/v…
GeneDx retweeted
Katherine Stueland, CEO of @GeneDx, on using early genomics to end the diagnostic odyssey and bring answers to more families.
Apple: hubs.ly/Q03WKvxB0
Spotify: hubs.ly/Q03WKwJs0
Acast:
hubs.ly/Q03WKrqy0
#Genomics #PrecisionMedicine #RareDisease #screening
GeneDx retweeted
Up to 50% of unexplained epilepsy cases have a genetic cause, yet many go undetected.
Dr. Isabella Herman of Boys Town National Research Hospital shares how genetic testing is transforming epilepsy care.
This #EpilepsyAwarenessMonth, we’re teaming with @GeneDx to highlight how genetic testing can uncover the root cause of seizures and help providers deliver more precise, personalized care.
GeneDx retweeted
👏 Thrilled to have @GeneDx join #FierceHealthPayerSummit 2025 as a Gold Partner! Dec 3–5 in Nashville — payers, providers & innovators unite to address prior authorization & health equity.
Details: loom.ly/hpmW45g
#HealthPayer
Replying to @GeneDx
@GeneDx is making waves at NSGC 2025! Showcasing breakthroughs in genomics & precision medicine.
Read Complete News at: towardshealthcare.com/news/g… #MedicalInnovation #GenomicsResearch
#Genomics #PrecisionMedicine #NSGC2025 #HealthcareInnovation
GeneDx retweeted
Howard McLeod Started a New Position as Senior Vice President of Clinical Affairs at GeneDx
@mcleodhoward @GeneDx
oncodaily.com/career/howard-…
#Cancer #Medicine #Health #Oncology #OncoDaily #GeneDx #MedX #MedNews #MedEd
GeneDx retweeted
Fabric Genomics and @GeneDx are enabling decentralized testing powered by centralized intelligence. Together, we harness the power of data to deliver actionable genomic insights. Visit us at #ASHG2025
bit.ly/3KMkVGW
#WGS
What’s next for #GeneTherapy and #CellTherapy?
#NORD + @ASGCTherapy co-hosted a #NORDSummit panel on promising, cutting-edge science—and the challenges of access, affordability and equity. Featuring experts from @UMassChan and @GeneDx.
Patient voices + FUNDING = New treatments
GeneDx retweeted
At ASHG, Illumina Pilots Products for Mapped Reads, Multiomics
The company shared pilot data about its Constellation tech and released 5-Base, a product for jointly analyzing genetic and epigenetic data
@illumina @GeneDx
#multiomics #DNAmethylation #ASHG
hubs.li/Q03P9lZl0
GeneDx retweeted
We’ve spent years pushing the limits of what short-read sequencing can do. Now, with our emerging constellation mapped read technology, we’re breaking new barriers and enabling the industry to uncover even deeper insights from the genome.
@GeneDx recently piloted constellation to evaluate its performance in the most challenging genomic regions. Early results illustrate its ability to rapidly identify hard-to-detect variants implicated in rare disease, like DMPK, SMN1, and mosaic aneuploidy.
Joe Devaney, Director of the Laboratory Innovation Team at GeneDx, said: “We’re continually looking to advance research and clinical genomics to drive the future of precision medicine and better health outcomes for all. The level of detail we can achieve with Constellation provides promising insight into some of the world’s most complex and difficult-to-diagnose diseases.”
Constellation delivers long-range genomic insights with a simplified, on-flow-cell library prep that removes manual steps — all within the workflows our customers know and trust.
📍GeneDx presented the results of their pilot today at #ASHG25. Read more here: bit.ly/4oaVLkh
GeneDx retweeted
.@EinsteinMed is joining BEACONS—the first multi-state pilot initiative to integrate whole genome sequencing into standard newborn screening and study how it can identify genetic conditions in the first year of life. @GeneDx @MassGenBrigham ir.genedx.com/news-releases/…
Meet this year’s #NORDSummit Lightning Round Poster Presenters!
Featuring top #RareDisease research from @medliveofficial, @CureCastleman, @GeneDx, @AFTDHope, @AlexionPharma & @ArrowheadPharma.
Register to attend on Oct. 20 to learn about their work! 👉 bit.ly/4lSAkDq
GeneDx retweeted
SAVE THE DATE!
With global developmental delay (GDD) & intellectual disability (ID) now affecting more than 8% of children in the US, staying current on genetic diagnosis is critical.
Join our live event.
🗓️ September 18, 2025
⏰ 1:30 PM EDT
➡️ youtube.com/watch?v=OrsM4VGs…
#CME
GeneDx retweeted
"Earlier testing gives families and clinicians more options," says @GeneDx CEO Katherine Stueland on the fight against rare diseases. cnb.cx/3H1DPrS





























